European Healthcare Acquisition & Growth Company B.V. Stock price

Equities

EHCS

NL0015000K10

Investment Holding Companies

Real-time Euronext Amsterdam 06:05:01 2024-03-22 am EDT 5-day change 1st Jan Change
9.15 EUR -8.04% Intraday chart for European Healthcare Acquisition & Growth Company B.V. -8.04% -8.50%
Sales 2021 - Sales 2022 - Capitalization 199M 184M
Net income 2021 -5M -4.63M Net income 2022 -30M -27.8M EV / Sales 2021 -
Net cash position 2021 208M 193M Net cash position 2022 204M 189M EV / Sales 2022 -
P/E ratio 2021
-3.25 x
P/E ratio 2022
-2.2 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 11.32%
More Fundamentals * Assessed data
Dynamic Chart
European Healthcare Acquisition & Growth Shareholders Back Extension of Business Combination Deadline MT
Tranche Update on European Healthcare Acquisition & Growth Company B.V.'s Equity Buyback Plan announced on October 4, 2023. CI
European Healthcare Acquisition & Growth Company B.V.'s Equity Buyback announced on October 4, 2023, has expired with 18,761,038 shares, representing 93.8% for ?190.8 million. CI
European Healthcare Acquisition & Growth Proposes Extension to Merger Completion Deadline MT
European Healthcare Acquisition & Growth Company B.V. announces an Equity Buyback. CI
European Healthcare Acquisition & Growth Company B.V. authorizes a Buyback Plan. CI
European Healthcare Acquisition & Growth Company B.V. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
European Healthcare Acquisition & Growth to Propose Extension to Business Combination Deadline MT
European Healthcare Acquisition & Growth, Croma-Pharma Cancel Merger Talks MT
CROMA-PHARMA GmbH cancelled the acquisition of European Healthcare Acquisition & Growth Company B.V. in reverse merger transaction. CI
European Healthcare Acquisition & Growth Drops Croma-Pharma Merger from General Meeting Agenda MT
European Healthcare Acquisition & Growth Company B.V. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
European Healthcare Acquisition & Growth Company B.V. Auditor Raises 'Going Concern' Doubt CI
European Healthcare Acquisition & Growth Company B.V. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
European Healthcare SPAC To Merge With Austrian Aesthetic Medicine-focused Croma-Pharma MT
More news
1 day-8.04%
1 week-8.04%
6 months-7.58%
Current year-8.50%
More quotes
1 week
9.15
Extreme 9.15
9.15
1 month
9.15
Extreme 9.15
9.95
Current year
9.15
Extreme 9.15
10.00
1 year
9.00
Extreme 9
10.50
3 years
9.00
Extreme 9
11.00
5 years
9.00
Extreme 9
11.00
10 years
9.00
Extreme 9
11.00
More quotes
Date Price Change Volume
24-03-27 9.15 0.00% 0
24-03-26 9.15 0.00% 0
24-03-25 9.15 0.00% 0
24-03-22 9.15 -8.04% 300
24-03-21 9.95 0.00% 0

Real-time Euronext Amsterdam, March 22, 2024 at 06:05 am EDT

More quotes
European Healthcare Acquisition & Growth Company B.V. is a Special Purpose Acquisition Company (SPAC) aimed at acquiring companies with principal operations in Europe in the healthcare sector, with a special focus on the subsectors Biotechnology and Specialty Pharma, Pharma Services, Medical Technology and Medical Devices, Diagnostic and Lab Services, Bioinformatics as well as Life Science Tools.
More about the company
  1. Stock
  2. Equities
  3. Stock European Healthcare Acquisition & Growth Company B.V. - Euronext Amsterdam